Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2650-2653

  Murayama, Somay Yamagata ^a   Seki, Chizuko ^a   Sakata, Hiroshi ^b   Sunaoshi, Katsuhiko ^a   Nakayama, Eiichi ^a   Iwata, Satoshi ^c   Sunakawa, Keisuke ^a   Ubukata, Kimiko ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Asahikawa Kosei Hospital   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFAZOLIN; CEFDINIR; CEFDITOREN; CEFOTAXIME; CEFOTIAM; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MEROPENEM; PANIPENEM; PENICILLIN G;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHILD; CORRELATION ANALYSIS; GROUP B STREPTOCOCCAL INFECTION; GYRA GENE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PARC GENE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEPSIS; STREPTOCOCCUS AGALACTIAE;

ADOLESCENT; ADULT; AGED; BACTERIAL CAPSULES; CHILD; CHILD, PRESCHOOL; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN; POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE;

EID: 67049134632     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01716-08     Document Type: Article

References (23)

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. 1997. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99:489-496.
2. American College of Obstetrics and Gynecologists Committee on Obstetric Practice. 1996. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 1996. Int. J. Gynaecol. Obstet. 54:197-205.
3. Baker, C. J., F. F. Barrett, R. C. Gordon, and M. D. Yow. 1973. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J. Pediatr. 82:724-729.
4. Barton, L. L., R. D. Feigin, and R. Lins. 1973. Group B beta hemolytic streptococcal meningitis in infants. J. Pediatr. 82:719-723.
5. Benson, J. A., and P. Ferrieri. 2001. Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J. Clin. Microbiol. 39:3006-3008.
6. Centers for Disease Control and Prevention. 2000. From the Centers for Disease Control and Prevention: early-onset group B streptococcal disease - United States, 1998-1999. JAMA 284:1508-1510.
7. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recommend. Rep. 45:1-24.
8. Chiba, N., R. Kobayashi, K. Hasegawa, M. Morozumi, E. Nakayama, T. Tajima, S. Iwata, and K. Ubukata. 2005. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. J. Antimicrob. Chemother. 56:756-760.
9. Franciosi, R. A., J. D. Knostman, and R. A. Zimmerman. 1973. Group B streptococcal neonatal and infant infections. J. Pediatr. 82:707-718.
10. Kawamura, Y., H. Fujiwara, N. Mishima, Y. Tanaka, A. Tanimoto, S. Ikawa, Y. Itoh, and T. Ezaki. 2003. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Chemother. 47:3605-3609. (Pubitemid 37345728)
11. Kimura, K., S. Suzuki, J. Wachino, H. Kurokawa, K. Yamane, N. Shibata, N. Nagano, H. Kato, K. Shibayama, and Y. Arakawa. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:2890-2897.
12. Lindahl, G., M. Stalhammar-Carlemalm, and T. Areschoug. 2005. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 18:102-127.
13. Miró, E., M. Rebollo, A. Rivera, M. T. Alvarez, F. Navarro, B. Mirelis, and P. Coll. 2006. Streptococcus agalactiae highly resistant to fluoroquinolones. Enferm. Infecc. Microbiol. Clin. 24:562-563.
14. Nizet, V., and C. E. Rubens. 2006. Pathogenic mechanisms and virulence factors of group B streptococci, p. 152-168. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens, 2nd ed. ASM press, Washington, DC.
15. Phares, C. R., R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffner, S. M. Zansky, K. Gershman, K. R. Stefonek, B. A. Albanese, E. R. Zell, A. Schuchat, and S. J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065.
16. Poyart, C., A. Tazi, H. Reglier-Poupet, A. Billoet, N. Tavares, J. Raymond, and P. Trieu-Cuot. 2007. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J. Clin. Microbiol. 45:1985-1988.
17. Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recommend. Rep. 51:1-22.
18. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
19. Ubukata, K., N. Chiba, K. Hasegawa, R. Kobayashi, S. Iwata, and K. Sunakawa. 2004. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob. Agents Chemother. 48:1488-1494.
20. Ubukata, K., K. Sunaoshi, R. Kobayashi, and K. Okuzumi. 2006. Large-scale questionnaire surveillance concerning invasive infections with group C and G streptococci. Kansenshogaku Zasshi 80:480-487.
21. Wajima, T., S. Y. Murayama, K. Sunaoshi, E. Nakayama, K. Sunakawa, and K. Ubukata. 2008. Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. J. Med. Microbiol. 57:1383-1388.
22. Wehbeh, W., R. Rojas-Diaz, X. Li, N. Mariano, L. Grenner, S. Segal-Maurer, B. Tommasulo, K. Drlica, C. Urban, and J. J. Rahal. 2005. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother. 49:2495-2497.
23. Zangwill, K. M., A. Schuchat, and J. D. Wenger. 1992. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR Surveill. Summ. 41:25-32.